U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07735143) titled 'iMORE+ Study: A Multi-Omics Cohort Study of Major Depressive Disorder' on July 20.
Brief Summary: Major depressive disorder (MDD) is a common mental health condition characterized by substantial clinical heterogeneity and variability in treatment response. Current diagnosis and treatment selection for MDD mainly rely on clinical assessments, and reliable biological markers that can support diagnosis, predict antidepressant treatment response, guide personalized treatment, and improve understanding of disease mechanisms remain limited.
The goal of this prospective observational cohort study is to develop and optimize multi-omics-bas...